SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 1st, 2020 • Quanta Inc • Medicinal chemicals & botanical products • New York
Contract Type FiledMay 1st, 2020 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 27, 2020, by and between Quanta, Inc., a Nevada corporation, with headquarters located at 3606 W. Magnolia Blvd., Burbank, CA 91505 (the “Company”), and certain accredited investors set forth on the signature page below (each a “Buyer” and collectively the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 16th, 2022 • Quanta Inc • Medicinal chemicals & botanical products • Nevada
Contract Type FiledJune 16th, 2022 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 12, 2021, by and between QUANTA, INC., a Nevada corporation, with its address at 632 S. Glenwood Place, Burbank, CA 91505 (the “Company”), and TRILLIUM PARTNERS L.P., a Delaware limited partnership, with its address at Executive Pavilion 90 Grove Street, Ridgefield CT 06877 (the “Buyer”).
EQUITY PURCHASE AGREEMENT BY AND BETWEEN QUANTA, INC. AND OSCALETA PARTNERS LLC Dated April 9, 2020Equity Purchase Agreement • April 10th, 2020 • Quanta Inc • Medicinal chemicals & botanical products • New York
Contract Type FiledApril 10th, 2020 Company Industry JurisdictionTHIS EQUITY PURCHASE AGREEMENT entered into as of the 9th day of April 2020 (this “AGREEMENT”), by and between OSCALETA PARTNERS LLC, a Connecticut limited partnership (“INVESTOR”), and QUANTA, INC., a Nevada corporation (the “COMPANY”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 10th, 2020 • Quanta Inc • Medicinal chemicals & botanical products • New York
Contract Type FiledApril 10th, 2020 Company Industry JurisdictionThis Registration Rights Agreement (“Agreement”), dated April 09, 2020, is made by and between QUANTA, INC., a Nevada corporation (“Company”), and OSCALETA PARTNERS LLC, Connecticut limited liability company (the “Investor”).
QUANTA, INC. SUBSCRIPTION AGREEMENTSubscription Agreement • February 9th, 2021 • Quanta Inc • Medicinal chemicals & botanical products • Nevada
Contract Type FiledFebruary 9th, 2021 Company Industry JurisdictionTHIS SUBSCRIPTION AGREEMENT made as of the _____ day of __________________, 2021 between QUANTA, INC., a corporation organized under the laws of the State of Nevada, (the “Company”), and the undersigned (the “Subscriber” and together with each of the other subscribers in the Offering (defined below), the “Subscribers”).
SUBSCRIPTION AGREEMENTSubscription Agreement • June 18th, 2021 • Quanta Inc • Medicinal chemicals & botanical products • Florida
Contract Type FiledJune 18th, 2021 Company Industry JurisdictionThis subscription agreement (this “Subscription Agreement” or the “Agreement”) is entered into by and between QUANTA, INC., a Nevada corporation (hereinafter the “Company”) and the undersigned (hereinafter the “Investor”) as of the date set forth on the signature page hereto. Any term used but not defined herein shall have the meaning set forth in the Offering Circular (as defined below).
Joint Venture AgreementJoint Venture Agreement • September 25th, 2018 • Quanta Inc • Services-computer integrated systems design • California
Contract Type FiledSeptember 25th, 2018 Company Industry JurisdictionThis Joint Venture Agreement ("Agreement"), made on September 5, 2018 by and between QUANTA, of 3606 W MAGNOLIA BLVD, BURBANK, California 91505 and 2664431 Ontario Inc. (Quanta Canada) of 11 BUTTERMILL AVE, CONCORD, ONTARIO, CANADA L4K 3X1. The parties are hereinafter sometimes referred to together as the "Joint Venturers" or the "Parties" and individually as a "Joint Venturer" or "Party."
EMPLOYMENT AGREEMENTEmployment Agreement • September 5th, 2019 • Quanta Inc • Services-computer integrated systems design • California
Contract Type FiledSeptember 5th, 2019 Company Industry JurisdictionThis EMPLOYMENT AGREEMENT (this “Agreement”) is effective as of September 4, 2019 (the “Effective Date”), by and between Quanta, Inc., a California corporation (the “Company”), and Jeff Doiron (the “Employee”). The Company and the Employee are sometimes hereinafter referred to individually as a “Party” and together as “Parties.”
ESCROW AGREEMENTExhibit 99 • May 1st, 2017 • Freight Solution Inc • Services-computer integrated systems design • California
Contract Type FiledMay 1st, 2017 Company Industry JurisdictionThis agreement (this “Agreement”) is dated as of March 27, 2017 by and between Freight Solution, Inc. (“Company”) located at 8506 Strong Avenue, Orangevale, California 95662 and Krueger LLP located at 7486 La Jolla Boulevard, La Jolla, California 92037 (“Escrow Agent”).
SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • December 22nd, 2020 • Quanta Inc • Medicinal chemicals & botanical products • Nevada
Contract Type FiledDecember 22nd, 2020 Company Industry JurisdictionThis Securities Exchange Agreement (this “Agreement”) is dated as of December 21, 2020, by and among the shareholders of Medolife Rx, Inc., representing fifty-one percent (51%) of the total outstanding shares, thereof (collectively the “Seller”), Medolife Rx, Inc., a Wyoming corporation (the “Company”), and Quanta, Inc., a Nevada corporation (the “Purchaser”).
ESCROW AGREEMENTEscrow Agreement • June 1st, 2017 • Freight Solution Inc • Services-computer integrated systems design • California
Contract Type FiledJune 1st, 2017 Company Industry JurisdictionThis agreement (this “Agreement”) is dated as of March 27, 2017 by and between Freight Solution, Inc. (“Company”) located at 8506 Strong Avenue, Orangevale, California 95662 and Krueger LLP located at 7486 La Jolla Boulevard, La Jolla, California 92037 (“Escrow Agent”).
SHARE CANCELLATION AGREEMENTShare Cancellation Agreement • November 18th, 2020 • Quanta Inc • Medicinal chemicals & botanical products • Nevada
Contract Type FiledNovember 18th, 2020 Company Industry JurisdictionTHIS SHARE CANCELLATION AGREEMENT (“Agreement”) is made effective as of this 16th day of November, 2020 by and between QUANTA, INC., a Nevada corporation with an address at 3606 W. Magnolia Blvd., Burbank, CA 91505 (“Pubco”) and Eric Rice, a shareholder in Pubco (“Shareholder”)
AGREEMENT AND PLAN OF MERGER AND REORGANIZATIONAgreement and Plan of Merger and Reorganization • June 18th, 2018 • Freight Solution Inc • Services-computer integrated systems design • Nevada
Contract Type FiledJune 18th, 2018 Company Industry JurisdictionThis Agreement and Plan of Merger and Reorganization (this “Agreement”) is entered into as of June 6, 2018 by and among FREIGHT SOLUTION, INC., a publicly-owned Nevada corporation (the “Company”), QUANTA ACQUISITION CORP., a California corporation (“Acquisition”), and Bioanomaly, Inc. a California corporation d/b/a Quanta (“Quanta”). The Company, Acquisition and Quanta are sometimes hereinafter collectively referred to as the “Parties” and individually as a “Party.”
Freight Solution, Inc.Investor Subscription Agreement • June 18th, 2018 • Freight Solution Inc • Services-computer integrated systems design • Nevada
Contract Type FiledJune 18th, 2018 Company Industry JurisdictionINVESTOR SUBSCRIPTION AGREEMENT (the “Subscription Agreement”) between Freight Solution, Inc., a Nevada corporation (the “Company”) and the person or persons executing this Agreement on the execution page hereof (the “Subscriber”). All documents mentioned herein are incorporated by reference.
FREIGHT SOLUTION, INC. SUBSCRIPTION AGREEMENTSubscription Agreement • March 27th, 2017 • Freight Solution Inc • Nevada
Contract Type FiledMarch 27th, 2017 Company Jurisdiction
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 26th, 2019 • Quanta Inc • Medicinal chemicals & botanical products • New York
Contract Type FiledNovember 26th, 2019 Company Industry JurisdictionThis Registration Rights Agreement (“Agreement”), dated November 25, 2019, is made by and among QUANTA, INC., a Nevada corporation (“Company”), and the purchasers listed on the signature pages hereto (each a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 26th, 2019 • Quanta Inc • Medicinal chemicals & botanical products • New York
Contract Type FiledNovember 26th, 2019 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of November 25, 2019, by and between Quanta, Inc., a Nevada corporation, with headquarters located at 3606 W Magnolia Blvd, Burbank CA, 91505 (the “Company”), and the purchasers listed on the signature page hereto (each a “Purchaser” and collectively the “Purchasers”).
ContractQuanta Inc • April 10th, 2020 • Medicinal chemicals & botanical products • Illinois
Company FiledApril 10th, 2020 Industry Jurisdiction[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.
CONTROL BLOCK SHARE TRANSFER AGREEMENTControl Block Share Transfer Agreement • May 11th, 2021 • Quanta Inc • Medicinal chemicals & botanical products • Nevada
Contract Type FiledMay 11th, 2021 Company Industry JurisdictionTHIS CONTROL BLOCK SHARE TRANSFER AGREEMENT (the “Agreement”) is made effective as of the 10th day of May, 2021, by and among QUANTA, INC., a Nevada corporation (“Pubco” or “QNTA”) and Phil Sands, the majority shareholder in Pubco (“Controlling Shareholder”) and Arthur Mikaelian.
CONTROL BLOCK SHARE TRANSFER AGREEMENTControl Block Share Transfer Agreement • November 18th, 2020 • Quanta Inc • Medicinal chemicals & botanical products • Nevada
Contract Type FiledNovember 18th, 2020 Company Industry JurisdictionTHIS CONTROL BLOCK SHARE TRANSFER AGREEMENT is made effective as of the 16th day of November, 2020, by and among QUANTA, INC., a Nevada (“Pubco” or “QNTA”) and Eric Rice, the majority shareholder in Pubco (“Controlling Shareholder”) and Phil Sands.